PR Newswire - Jacobio Pharma Presents SHP2 Plus KRAS G12C Data a...
BEIJING and SHANGHAI and CHICAGO, June 2, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, presented updated data of a KRAS G12C inhibi...
Read More


ภาษาไทย
English